Renascience, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3981100005
JPY
1,730.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
132.69
194.16
100.55
139.33
209.80
72.01
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
132.69
194.16
100.55
139.33
209.80
72.01
Raw Material Cost
3.81
30.36
1.63
61.74
32.84
23.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
5.37
7.50
0.68
Selling and Distribution Expenses
158.15
166.32
183.91
192.27
180.89
200.37
Other Expenses
13.29
23.63
23.52
7.73
7.39
2.53
Total Expenditure (Excl Depreciation)
294.83
433.01
420.78
336.72
295.16
249.41
Operating Profit (PBDIT) excl Other Income
-162.10000000000002
-238.79999999999998
-320.20000000000005
-197.39999999999998
-85.39999999999999
-177.39999999999998
Other Income
-0.16
0.46
0.03
-25.56
2.83
-0.01
Operating Profit (PBDIT)
-178.93
-249.93
-332.29
-233.33
-80.21
-180.10
Interest
0.00
0.00
0.00
5.37
7.50
0.68
Exceptional Items
322.75
-4.50
0.00
-11.32
-9.00
0.00
Gross Profit (PBDT)
128.88
163.81
98.92
77.60
176.96
48.97
Depreciation
0.06
1.95
1.54
3.37
3.08
3.04
Profit Before Tax
143.76
-256.38
-333.84
-253.09
-99.76
-183.80
Tax
30.34
1.96
1.96
1.20
0.30
0.29
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.43
-258.33
-335.80
-254.29
-100.05
-184.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.43
-258.33
-335.80
-254.29
-100.05
-184.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
113.43
-258.33
-335.80
-254.29
-100.05
-184.09
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,720.15
1,606.72
1,865.06
2,200.86
561.53
621.59
Earnings per share (EPS)
8.92
-20.32
-26.42
-22.33
-8.15
-15.0
Diluted Earnings per share
8.92
-20.32
-26.42
-22.33
-8.15
-15.0
Operating Profit Margin (Excl OI)
-134.77%
-129.96%
-332.06%
-151.54%
-41.05%
-254.3%
Gross Profit Margin
108.39%
-131.04%
-330.49%
-179.22%
-46.08%
-251.01%
PAT Margin
85.48%
-133.05%
-333.98%
-182.51%
-47.69%
-255.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -31.67% vs 93.23% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 143.90% vs 23.08% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 28.59% vs 24.65% in Mar 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Renascience, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
132.69
316.00
-183.31
-58.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
132.69
316.00
-183.31
-58.01%
Raw Material Cost
3.81
326.00
-322.19
-98.83%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
5.00
-5.00
-100.00%
Selling and Distribution Expenses
158.15
567.00
-408.85
-72.11%
Other Expenses
13.29
40.90
-27.61
-67.51%
Total Expenditure (Excl Depreciation)
294.83
1,307.00
-1,012.17
-77.44%
Operating Profit (PBDIT) excl Other Income
-162.13
-991.00
828.87
83.64%
Other Income
-0.16
0.00
-0.16
Operating Profit (PBDIT)
-178.93
-796.00
617.07
77.52%
Interest
0.00
5.00
-5.00
-100.00%
Exceptional Items
322.75
-959.00
1,281.75
133.65%
Gross Profit (PBDT)
128.88
-10.00
138.88
1,388.80%
Depreciation
0.06
195.00
-194.94
-99.97%
Profit Before Tax
143.76
-1,957.00
2,100.76
107.35%
Tax
30.34
-19.00
49.34
259.68%
Provisions and contingencies
0
0
0.00
Profit After Tax
113.43
-1,941.00
2,054.43
105.84%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
113.43
-1,941.00
2,054.43
105.84%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
113.43
-1,941.00
2,054.43
105.84%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,720.15
1,156.00
564.15
48.80%
Earnings per share (EPS)
8.92
-9.77
18.69
191.30%
Diluted Earnings per share
8.92
-9.77
18.69
191.30%
Operating Profit Margin (Excl OI)
-134.77%
-313.61%
0.00
178.84%
Gross Profit Margin
108.39%
-557.59%
0.00
665.98%
PAT Margin
85.48%
-614.24%
0.00
699.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 13.27 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -31.67% vs 93.23% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 11.34 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 143.90% vs 23.08% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -17.88 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 28.59% vs 24.65% in Mar 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -134.77%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024